Position in PRFX
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$39,433
+$12,663 QoQ
Shares Held
28,575
+116.1% QoQ
Ownership
0.939%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 8 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRFX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $1,255,121,114 across 64 Drug Manufacturers - Specialty & Generic names. PRFX ranks #58 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
9,668,611 | $237,944,516 | |
| 2 | ZTS |
Zoetis Inc.
|
3,188,263 | $229,108,578 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
304,692 | $165,091,266 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
1,376,480 | $152,706,691 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,667,827 | $109,460,941 | |
| 6 | ALKS |
Alkermes plc.
|
1,645,101 | $86,203,291 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,373,982 | $63,903,902 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
846,936 | $29,363,271 |
All Filings in PRFX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,433 | 28,575 | Shares | Defined | 2026-09-02 | |
| 2026-03-31 | $26,770 | 13,220 | Shares | Defined | 2026-05-15 | |
| 2024-03-31 | $31,211 | 17,149 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $10,966 | 19,976 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $10,514 | 15,239 | Shares | Defined | 2022-11-14 | |
| 2021-09-30 | $32,234 | 11,637 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $95,132 | 33,735 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $122,265 | 27,662 | Shares | Defined | 2021-05-21 | |
| No filing history on record for this holder in this stock. | ||||||